Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SPFPL DE PHARMACIENS D'OFFICINE B.P.R. : revenue, balance sheet and financial ratios

SPFPL DE PHARMACIENS D'OFFICINE B.P.R. is a French company founded 2 years ago, specialized in the sector Activités des sièges sociaux. Based in BIARRITZ (64200), this company of category PME shows in 2025 a net income positive of 31 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-18

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SPFPL DE PHARMACIENS D'OFFICINE B.P.R. (SIREN 953341492)
Indicator 2025 2024 2023
Revenue N/C N/C N/C
Net income 30 502 € -26 257 € 0 €
EBITDA -7 846 € -18 438 € N/C
Net margin N/C N/C N/C

Revenue and income statement

In 2025, SPFPL DE PHARMACIENS D'OFFICINE B.P.R. generates positive net income of 31 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.

EBITDA (2025) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

-7 846 €

EBIT (2025) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

-7 853 €

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

30 502 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 5026%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 2%. Low autonomy: the company heavily depends on external financing (banks, suppliers). Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 19.4 years of cash flow to repay all financial debt. Beyond 7 years, banks generally consider credit risk as high.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

5026.253%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

1.944%

Repayment capacity (2025) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

19.428

Solvency indicators evolution
SPFPL DE PHARMACIENS D'OFFICINE B.P.R.

Sector positioning

Debt ratio
5026.25 2025
2023
2024
2025
Q1: 0.1
Med: 12.78
Q3: 79.19
Watch

In 2025, the debt ratio of SPFPL DE PHARMACIENS D'OF... (5026.25) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.

Financial autonomy
1.94% 2025
2023
2024
2025
Q1: 14.33%
Med: 56.86%
Q3: 88.94%
Average

In 2025, the financial autonomy of SPFPL DE PHARMACIENS D'OF... (1.9%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
19.43 years 2025
2024
2025
Q1: 0.0 years
Med: 0.28 years
Q3: 3.37 years
Average +50 pts over 2 years

In 2025, the repayment capacity of SPFPL DE PHARMACIENS D'OF... (19.43) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 242.30. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

242.298

Interest coverage (2025) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

-2121.196

Liquidity indicators evolution
SPFPL DE PHARMACIENS D'OFFICINE B.P.R.

Sector positioning

Liquidity ratio
242.3 2025
2024
2025
Q1: 133.41
Med: 540.0
Q3: 2678.02
Average -43 pts over 2 years

In 2025, the liquidity ratio of SPFPL DE PHARMACIENS D'OF... (242.30) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
-2121.2x 2025
2024
2025
Q1: -44.22x
Med: 0.0x
Q3: 1.81x
Average

In 2025, the interest coverage of SPFPL DE PHARMACIENS D'OF... (-2121.2x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 119 days. Excellent situation: suppliers finance 119 days of the operating cycle (retail model).

Operating WCR (2025) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2025) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2025) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

119 j

Inventory turnover (2025) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SPFPL DE PHARMACIENS D'OFFICINE B.P.R.

Positioning of SPFPL DE PHARMACIENS D'OFFICINE B.P.R. in its sector

Comparison with sector Activités des sièges sociaux

Valuation estimate

Based on 54 transactions of similar company sales in 2025, the value of SPFPL DE PHARMACIENS D'OFFICINE B.P.R. is estimated at 84 326 € (range 25 411€ - 173 614€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2025
54 tx
25k€ 84k€ 173k€
84 326 € Range: 25 411€ - 173 614€
NAF 5 année 2025

Valuation method used

Net Income Multiple
30 502 € × 2.8x = 84 327 €
Range: 25 411€ - 173 614€

Only this financial indicator is available for this company.

How is this estimate calculated?

This estimate is based on the analysis of 54 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Activités des sièges sociaux)

Compare SPFPL DE PHARMACIENS D'OFFICINE B.P.R. with other companies in the same sector:

Voir toutes les statistiques du secteur Activités des sièges sociaux

Frequently asked questions about SPFPL DE PHARMACIENS D'OFFICINE B.P.R.

What is the revenue of SPFPL DE PHARMACIENS D'OFFICINE B.P.R. ?

The revenue of SPFPL DE PHARMACIENS D'OFFICINE B.P.R. is not publicly disclosed (confidential accounts filed with INPI).

Is SPFPL DE PHARMACIENS D'OFFICINE B.P.R. profitable?

Yes, SPFPL DE PHARMACIENS D'OFFICINE B.P.R. generated a net profit of 31 k€ in 2025.

Where is the headquarters of SPFPL DE PHARMACIENS D'OFFICINE B.P.R. ?

The headquarters of SPFPL DE PHARMACIENS D'OFFICINE B.P.R. is located in BIARRITZ (64200), in the department Pyrenees-Atlantiques.

Where to find the tax return of SPFPL DE PHARMACIENS D'OFFICINE B.P.R. ?

The tax return of SPFPL DE PHARMACIENS D'OFFICINE B.P.R. is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SPFPL DE PHARMACIENS D'OFFICINE B.P.R. operate?

SPFPL DE PHARMACIENS D'OFFICINE B.P.R. operates in the sector Activités des sièges sociaux (NAF code 70.10Z). See the 'Sector positioning' section above to compare the company with its competitors.